Isolagen Inc has received License No. 174347 from the Therapeutic Goods Administration (TGA), in Australia, to begin the manufacture of autologous fibroblasts including the initiation of primary cultures of fibroblasts, the propagation of fibroblasts, the harvesting of cultured fibroblasts, the storage of cultured fibroblasts and release for supply of cultured fibroblasts.
Isolagen expects to begin commercialization in Australia within the next few months.